https://www.targetedonc.com/view/fda-grants-fast-track-designation-to-novel-tkk1-therapy-for-er-her2--advanced-breast-cancer
0
0
1/10/23 at 8:23pm
Organization
Targetedonc.com
Author
Nichole Tucker
42 words
0
Comments
The investigational drug, CFI-402257, has earned the FDA’s attention for promising preclinical results, and is now under investigation in a phase 1 study.
You are the first to view
Create an account
or login to join the discussion